Skip to main content
. 2019 Apr 22;20:174. doi: 10.1186/s12891-019-2527-y

Fig. 3.

Fig. 3

Response rates at the end of the extension phase. The response rates were based on the change from baseline of the placebo-controlled phase to endpoint (last observation carried forward) in Brief Pain Inventory average pain rating. Abbreviations: DLX = duloxetine; PLA = placebo